CDC updates childhood immunization schedule, shifting recommendations while keeping coverage
Federal health officials announced changes to the U.S. childhood immunization schedule, reorganizing recommendations into categories while stating vaccines remain covered by insurance without cost-sharing.

The Centers for Disease Control and Prevention announced an overhaul of the U.S. childhood immunization schedule on January 5, 2026, following a presidential directive to compare U.S. practices with those of peer countries. The CDC said the updated framework reorganizes vaccines into three categories: those recommended for all children, those recommended for certain high-risk groups, and those offered through shared clinical decision-making between families and clinicians.

Under the CDC’s new structure, the agency highlighted a core set of vaccines that remain in the “recommended for all children” category, including immunizations for measles, mumps and rubella; polio; pertussis, tetanus and diphtheria; Hib; pneumococcal disease; HPV; varicella; and others listed in the CDC release. Federal officials emphasized that vaccines on the schedule remain covered by insurance without cost-sharing, even as recommendation categories change.
The announcement quickly triggered pushback from medical and public-health voices, who warned that changing what is routinely recommended could reduce uptake and increase the risk of vaccine-preventable disease. Critics argue that moving shots into high-risk or shared-decision categories could, in practice, make them less standard—particularly in busy clinical settings where default recommendations strongly influence what families choose.
The CDC and HHS framed the revisions as a transparency and trust effort, saying the policy is meant to align recommendations with international approaches while encouraging more evidence development. The agencies also pointed to declining public trust and falling vaccination rates in recent years as part of the context for the change.
For parents, the practical takeaway is that pediatric visits may involve more explicit conversations about certain vaccines, including risk-based and shared-decision choices, rather than a uniform set of default shots. Families are being urged by clinicians to discuss individual circumstances with pediatric providers and to follow updated schedules and guidance as states and schools review how recommendations interact with local requirements.